Nothing Special   »   [go: up one dir, main page]

ATE217905T1 - Zellinien, die einen biologisch aktiven faktor-ix exprimieren - Google Patents

Zellinien, die einen biologisch aktiven faktor-ix exprimieren

Info

Publication number
ATE217905T1
ATE217905T1 AT90913241T AT90913241T ATE217905T1 AT E217905 T1 ATE217905 T1 AT E217905T1 AT 90913241 T AT90913241 T AT 90913241T AT 90913241 T AT90913241 T AT 90913241T AT E217905 T1 ATE217905 T1 AT E217905T1
Authority
AT
Austria
Prior art keywords
promoter region
cell lines
gene
biologically active
hepatic cells
Prior art date
Application number
AT90913241T
Other languages
English (en)
Inventor
Sophie Jallat
Pierre Meulien
Andrea Pavirani
Frederic Perraud
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE217905T1 publication Critical patent/ATE217905T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90913241T 1989-08-09 1990-08-09 Zellinien, die einen biologisch aktiven faktor-ix exprimieren ATE217905T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8910720A FR2650838A1 (fr) 1989-08-09 1989-08-09 Vecteurs d'expression du facteur ix dans une cellule eucaryote superieure, procede de preparation de facteur ix par des animaux transgeniques et facteur ix obtenu
PCT/FR1990/000606 WO1991002056A1 (fr) 1989-08-09 1990-08-09 Lignees cellulaires exprimant un facteur ix biologiquement actif

Publications (1)

Publication Number Publication Date
ATE217905T1 true ATE217905T1 (de) 2002-06-15

Family

ID=9384606

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90913241T ATE217905T1 (de) 1989-08-09 1990-08-09 Zellinien, die einen biologisch aktiven faktor-ix exprimieren

Country Status (8)

Country Link
US (1) US5814716A (de)
EP (1) EP0437599B1 (de)
JP (1) JPH04501209A (de)
AT (1) ATE217905T1 (de)
CA (1) CA2039153A1 (de)
DE (1) DE69033961T2 (de)
FR (1) FR2650838A1 (de)
WO (1) WO1991002056A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1265794B1 (it) * 1992-09-07 1996-12-03 Angeletti P Ist Richerche Bio Mammiferi transgenici non umani con un oncogene sotto il controllo di un promotore inducibile fegato-specifico
DE4407859C1 (de) * 1994-03-04 1995-03-02 Max Planck Gesellschaft Vektor für die leberspezifische Gentherapie
US20040038898A1 (en) * 1996-05-16 2004-02-26 The Trustees Of Columbia University Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
US6740519B1 (en) * 1997-11-03 2004-05-25 Mount Sinai School Of Medicine Immortalized, homozygous stat1-deficient mammalian cell lines and their uses
US6610906B1 (en) * 1999-06-09 2003-08-26 The Regents Of The University Of Michigan Nucleotide sequences for gene regulation and methods of use thereof
WO2002040544A2 (en) * 2000-11-14 2002-05-23 Board Of Regents, University Of Texas Systems Mutant human factor ix with an increased resistance to inhibition by heparin
JP4842128B2 (ja) 2003-07-21 2011-12-21 トランジェーヌ、ソシエテ、アノニム 新規多機能性サイトカイン
WO2006076288A2 (en) * 2005-01-11 2006-07-20 Five Prime Therapeutics, Inc. Dna constructs for long-term expression of intravascularly injected naked dna
BR112012002628B1 (pt) 2009-08-07 2021-09-08 Transgene Sa Composição imunogênica, molécula de ácido nucleico, vetor, partícula viral infecciosa, micro-organismo transgênico, composição, usos da composição imunogênica e kit de partes
TWI575070B (zh) 2011-07-12 2017-03-21 傳斯堅公司 Ｈｂｖ聚合酶突變體
WO2013045658A1 (en) 2011-09-29 2013-04-04 Transgene Sa Immunotherapy composition and regimen for treating hepatitis c virus infection
TW201321016A (zh) 2011-09-29 2013-06-01 Transgene Sa 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（二）
EP2912069B1 (de) 2012-10-23 2019-07-31 Emory University Gm-csf- und il-4-konjugate, zusammensetzungen und zugehörige verfahren
EP3224380A1 (de) 2014-11-25 2017-10-04 The Broad Institute Inc. Klonale hämatopoese
EP3626832B1 (de) 2014-11-25 2024-06-12 The Brigham and Women's Hospital, Inc. Verfahren zur identifizierung einer person mit einer prädisposition für eine kardiometabolische krankheit oder eine davon betroffene person
KR102625470B1 (ko) * 2017-05-31 2024-01-16 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 최적화된 인간 응고 인자 ix 유전자 발현 카세트 및 이의 사용

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB223755A (en) * 1923-11-12 1924-10-30 Underwood Typewriter Company L Improvements relating to ink-ribbon mechanism for combined typewriting and computingmachines
JP2625412B2 (ja) * 1982-08-04 1997-07-02 ブリティッシュ・テクノロジー・グループ・リミテッド ヒト第９因子ポリペプチドをコードするｃｄｎａ
FR2564106B1 (fr) * 1984-05-09 1988-04-22 Transgene Sa Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
DE3545126A1 (de) * 1985-12-19 1987-06-25 Boehringer Mannheim Gmbh Verfahren zur verbesserung der expression von eukaryontenprotein
FR2637613B1 (fr) * 1987-06-19 1991-09-27 Transgene Sa Procede de preparation de lignees cellulaires stables pour la production de proteines determinees, a partir d'animaux transgeniques; lignees cellulaires tumorales et proteines obtenues
JP2796547B2 (ja) * 1987-09-11 1998-09-10 ジェネンテク，インコーポレイテッド 組換え細胞培養中でのポリペプチド発現の増大法
GB2223755A (en) * 1988-09-21 1990-04-18 Cambridge Animal Biotech Tissue modification

Also Published As

Publication number Publication date
DE69033961D1 (de) 2002-06-27
DE69033961T2 (de) 2002-11-07
CA2039153A1 (fr) 1991-02-10
FR2650838A1 (fr) 1991-02-15
JPH04501209A (ja) 1992-03-05
EP0437599A1 (de) 1991-07-24
EP0437599B1 (de) 2002-05-22
US5814716A (en) 1998-09-29
WO1991002056A1 (fr) 1991-02-21

Similar Documents

Publication Publication Date Title
ATE217905T1 (de) Zellinien, die einen biologisch aktiven faktor-ix exprimieren
AU7945682A (en) Rennin from recombinant dna
AU2126688A (en) Serum free media for the growth of insect cells and expression of products thereby
DK0770136T3 (da) Fremgangsmåde til at selektere höjtudtrykkende værtsceller
DE69422034D1 (de) Isolierung, selektion und vermehrung von tierischen transgen-stammzellen
ATE163046T1 (de) Genetische veränderung von endothelzellen
DK0843961T3 (da) Kimærisk mus og fremgangsmåde til at producere samme
DK309387D0 (da) Humant erythropoietin-gen samt expression deraf i transficerede celler
ATE92530T1 (de) Transformation und expression eines fremden gens in -i(brassica) spezies.
JP2008086326A (ja) ゲノム性要素を使用する遺伝子の操作および発現
DE3853474D1 (de) Vektor zur integrationsstellenunabhängigen genexpression in säugetier-wirtszellen.
ATE15693T1 (de) Zellkultur-verfahren.
EP0837931A4 (de) Methode zur expression in und isolation von biologisch aktiven molekülen aus urin
ATE243741T1 (de) Zufuhr von genprodukten mittels mesangium-zellen
CA2298412A1 (en) Identification of human cell lines for the production of human proteins by endogenous gene activation
RU94043769A (ru) Способ повышения продукции протеина с, способ повышения уровня его модификации
DE69130704D1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns-sequencen, und ihre herstellung und vewendung.
AU2209988A (en) Method for increasing the expression of polypeptides in recombinant cell culture
ES2003462A6 (es) Un metodo de obtencion de un alto nivel de expresion de una proteina.
DK0430635T3 (da) Bakterialt collagenasegen
AU581819B2 (en) Process for the immortalization of human and animal cells
ES2047946T3 (es) Metodos de cultivos celulares para producir proteina c activada.
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
ATE288476T1 (de) Herstellung von proteinen
DE58909205D1 (de) Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee